Glycemic deterioration is a typical complication of COVID-19 in patients with impaired glucose regulation or diabetes and in patients requiring insulin, SARS-CoV-2 infection was associated with a rapidly increasing need for high doses of insulin [17]. The gene discussed is INS; the disease is diabetes mellitus.